Intellex Acquires Expert by Big Village

We're thrilled to announce that Intellex has acquired Expert by Big Village, effective March 22, 2024. This strategic move enhances our capabilities and strengthens our commitment to delivering exceptional solutions to our customers.

Stay tuned for more updates on how this acquisition will benefit our clients and experts.

For inquiries or more information, please contact us at info@intellex.com.

×

Expert Details

Biotech/Pharma; Marketing Rare Disease and Specialty Products

ID: 737078 Switzerland

Request Expert

After graduating with a Master in Biotechnology and Business Administration and a career in molecular diagnostics and medical devices, Expert redirected his marketing career in Biopharma 12 years ago. He has been driving the global marketing strategy of drugs in rare disease and specialty medicines, from niche indications to blockbusters. As an international marketing professional, he has been involved in product launches, life-cycle management based on differentiation, drug add-ons such as mobile health and injection devices, disease awareness, commercial excellence, and geographic expansion.

Education

Year Degree Subject Institution
Year: 2002 Degree: MBA Subject: Business Administration Institution: ESCP
Year: 1995 Degree: MSc Subject: Biotechnology Institution: UST Lille 1

Work History

Years Employer Title Department
Years: 2021 to Present Employer: Undisclosed Title: Global Brand Leader Department: Hematology
Responsibilities:
Driving Doptelet ex-US brand strategy in two rare hematology disease indications.
Supporting ex-US launches and fine-tuning the product positioning to maximize market penetration.
Preparing the commercial launch of a Patient Support MedDev. App. Defining and deploying the brand multichannel/digital strategy.
Developing long-term LCM plan ensuring continuous differentiation to face increasing
competition.
Years Employer Title Department
Years: 2019 to 2021 Employer: Takeda Title: Senior Director Global Strategic Marketing Department: Gastro-enterology
Responsibilities:
Headed Gattex/Revestive (SBS-IF indication) brand strategy. Drove the Global Brand Planning process.
Defined the multi-channel communication strategy for the brand aimed at improving patients’ diagnoses.
Drove the “ATLAS” European Public Affairs initiative with my European counterpart, targeting an increased recognition of intestinal failure.
Oversaw commercial development of a new generation reconstitution/injection device.
Years Employer Title Department
Years: 2014 to 2019 Employer: Shire Title: Global Commercial Lead Department: Neuroscience
Responsibilities:
Headed the Child & Adolescent Neuroscience Portfolio strategy with responsibility for Vyvanse, Intuniv, Equasym (ADHD) & BUCCOLAM (Pediatric epilepsy rescue medication).
Partnered with affiliates in preparing and optimizing product launches from L-24. Responsible to give Go/No Go at L-6, together with General Manager. Improved the commercial excellence capabilities in partnership with the International Commercial Team.
Responsible for the development and implementation of Global Brand Plans & Target Product Profiles.
Supervised symposiums, roadshows, speaker consortiums and webinars, and presence at congresses.
Years Employer Title Department
Years: 2012 to 2014 Employer: Anteis Title: Head of Marketing and Medical Communication Department: Healthcare
Responsibilities:
Led marketing strategy and activity for implantable devices portfolio (hyaluronic acid) in Ophthalmology and Rheumatology.
Headed a small team on preparation of Marketing and Communication activities such as congresses, symposiums, and website and managed the development of Marketing and Business Plans.
Launched one new product in cataract surgery: Rhexicoat. In addition, it redefined Synolis VA’s positioning in orthopedic visco-supplementation and developed a new global marketing campaign.
Acting Medical Communication Director, managed scientific communication, post-marketing studies, and KOL relationship; developed scientific posters for congresses and presented symposia in Europe and Asia.
Drove the Marketing Strategic Plan review process for the entire company (Healthcare & Esthetics).
Years Employer Title Department
Years: 2008 to 2012 Employer: Merck KGaA Title: Director Global Strategic Marketing Department: Endocrinology
Responsibilities:
In charge of Saizen, a human Growth Hormone (hGH) indicated in pediatric deficiency.
Co-led, with the Program Manager, development of a new liquid formulation of Saizen and led the final development of cool.click2, a needle-free injection device, both launched at an international level, proactively taking on cool.click2 outside allocated areas of responsibility to get it to market on time.
Prepared the organization and the market for the launch of Saizen liquid for 2 years, and launched this new formulation in several international countries.
Developed and deployed global marketing plans for the Saizen franchise (2 formulations, 3 injection devices, and communication software) and managed the product life cycle for each.
Developed a business concept for pharmacogenetic-based service, delivering treatment prognosis based on genetic mutation profiling with the aim of increasing the perceived value of the product.
Created patient-focused tactics, promotional campaigns, and training material and organized advisory boards.

Language Skills

Language Proficiency
French Native
English Fluent
German Beginner

Fields of Expertise

pharmaceutical launch, marketing brand management, strategic branding, new product launch, pharmaceutical life cycle management, product life cycle, multichannel, business valuation, commercial development, ehealth

Request Expert

Dev Tool:

Request: expert/biotech-pharma-marketing-rare-disease-and-specialty-products
Matched Rewrite Rule: expert/([^/]+)(?:/([0-9]+))?/?$
Matched Rewrite Query: experts=biotech-pharma-marketing-rare-disease-and-specialty-products&page=
Loaded Template: single-experts.php